Results 101 to 110 of about 3,759 (138)

Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo.

open access: yesJAMA Dermatol
Metz M   +10 more
europepmc   +1 more source

Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis. [PDF]

open access: yesDermatol Ther (Heidelb)
Ständer S   +8 more
europepmc   +1 more source

Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials. [PDF]

open access: yesDermatol Ther (Heidelb)
Stander S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy